Financial Snapshot

Revenue
$11.26B
TTM
Gross Margin
62.55%
TTM
Net Earnings
$1.088B
TTM
Current Assets
$4.710B
Q2 2024
Current Liabilities
$5.624B
Q2 2024
Current Ratio
83.75%
Q2 2024
Total Assets
$33.40B
Q2 2024
Total Liabilities
$16.80B
Q2 2024
Book Value
$16.60B
Q2 2024
Cash
P/E
32.67
Sep 13, 2024 EST
Free Cash Flow
$1.889B
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019
Revenue $11.30B $10.86B $9.545B $9.892B $8.480B
YoY Change 4.09% 13.76% -3.51% 16.65%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019
Revenue $11.30B $10.86B $9.545B $9.892B $8.480B
Cost Of Revenue $4.344B $4.281B $3.561B $3.794B $3.249B
Gross Profit $6.958B $6.577B $5.984B $6.098B $5.231B
Gross Profit Margin 61.56% 60.57% 62.69% 61.65% 61.69%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019
Selling, General & Admin $4.097B $4.483B $3.567B $3.811B $3.349B
YoY Change -8.61% 25.68% -6.4% 13.8%
% of Gross Profit 58.88% 68.16% 59.61% 62.5% 64.02%
Research & Development $297.0M $300.0M $256.0M $296.0M $267.0M
YoY Change -1.0% 17.19% -13.51% 10.86%
% of Gross Profit 4.27% 4.56% 4.28% 4.85% 5.1%
Depreciation & Amortization $309.0M $287.0M $268.0M $305.0M $260.0M
YoY Change 7.67% 7.09% -12.13% 17.31%
% of Gross Profit 4.44% 4.36% 4.48% 5.0% 4.97%
Operating Expenses $4.442B $4.752B $3.823B $4.107B $3.616B
YoY Change -6.52% 24.3% -6.92% 13.58%
Operating Profit $2.516B $1.825B $2.161B $1.991B $1.615B
YoY Change 37.86% -15.55% 8.54% 23.28%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019
Interest Expense -$468.0M -$207.0M -$34.00M -$31.00M -$10.00M
YoY Change 126.09% 508.82% 9.68% 210.0%
% of Operating Profit -18.6% -11.34% -1.57% -1.56% -0.62%
Other Income/Expense, Net -$11.00M $52.00M -$3.000M -$5.000M -$4.000M
YoY Change -121.15% -1833.33% -40.0% 25.0%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019
Pretax Income $1.628B $1.618B $1.636B $1.591B $886.0M
YoY Change 0.62% -1.1% 2.83% 79.57%
Income Tax $517.0M $499.0M $197.0M $410.0M $199.0M
% Of Pretax Income 31.76% 30.84% 12.04% 25.77% 22.46%
Net Earnings $1.049B $1.060B $1.390B $1.145B $655.0M
YoY Change -1.04% -23.74% 21.4% 74.81%
Net Earnings / Revenue 9.28% 9.76% 14.56% 11.58% 7.72%
Basic Earnings Per Share
Diluted Earnings Per Share $0.11 $0.11 $150.5K $124.0K $70.93K

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019
Cash & Short-Term Investments $1.044B $684.0M $347.0M $281.0M $323.0M
YoY Change 52.63% 97.12% 23.49% -13.0%
Cash & Equivalents $684.0M $1.000M $1.000M $1.000M
Short-Term Investments
Other Short-Term Assets $526.0M $50.00M $128.0M $188.0M $283.0M
YoY Change 952.0% -60.94% -31.91% -33.57%
Inventory $1.408B $1.348B $951.0M $949.0M $1.211B
Prepaid Expenses
Receivables $1.352B $1.487B $1.319B $1.349B $1.399B
Other Receivables $488.0M $384.0M $2.506B $2.241B $2.595B
Total Short-Term Assets $4.818B $4.059B $5.251B $5.008B $5.811B
YoY Change 18.7% -22.7% 4.85% -13.82%
Property, Plant & Equipment $1.902B $1.899B $1.662B $1.602B $1.621B
YoY Change 0.16% 14.26% 3.75% -1.17%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $366.0M $421.0M $343.0M $302.0M $267.0M
YoY Change -13.06% 22.74% 13.58% 13.11%
Total Long-Term Assets $29.24B $30.76B $29.20B $29.12B $29.90B
YoY Change -4.94% 5.33% 0.27% -2.6%
Total Assets $34.06B $34.82B $34.45B $34.13B $35.71B
YoY Change
Accounts Payable $1.855B $3.621B $1.369B $1.340B $1.201B
YoY Change -48.77% 164.5% 2.16% 11.57%
Accrued Expenses $1.276B $1.763B $1.412B $1.430B $1.436B
YoY Change -27.62% 24.86% -1.26% -0.42%
Deferred Revenue
YoY Change
Short-Term Debt $60.00M $0.00 $874.0M $348.0M $481.0M
YoY Change -100.0% 151.15% -27.65%
Long-Term Debt Due $596.0M $437.0M $30.00M $34.00M $40.00M
YoY Change 36.38% 1356.67% -11.76% -15.0%
Total Short-Term Liabilities $4.640B $4.370B $4.238B $4.014B $4.269B
YoY Change 6.18% 3.11% 5.58% -5.97%
Long-Term Debt $8.800B $10.00B $87.00M $105.0M $121.0M
YoY Change -12.03% 11397.7% -17.14% -13.22%
Other Long-Term Liabilities $399.0M $384.0M $289.0M $415.0M $395.0M
YoY Change 3.91% 32.87% -30.36% 5.06%
Total Long-Term Liabilities $9.199B $10.39B $376.0M $520.0M $516.0M
YoY Change -11.44% 2662.5% -27.69% 0.78%
Total Liabilities $17.45B $18.48B $8.096B $8.018B $8.390B
YoY Change -5.6% 128.31% 0.97% -4.43%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019
Basic Shares Outstanding
Diluted Shares Outstanding
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $35.548 Billion

About

Haleon Plc engages in the provision of personal healthcare products. The company is headquartered in Weybridge, Surrey and currently employs 24,000 full-time employees. The company went IPO on 2022-07-18. The firm's product portfolio includes five categories, including oral health, vitamins, minerals, and supplements (VMS), pain relief, respiratory health, digestive health and others. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA and LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The firm's digestive health and other product offerings also include skin health and smoker’s health. Its oral health brands include Sensodyne, Polident, Parodontax, and Biotene. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, and Flonase. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Fenistil.

Industry: Perfumes, Cosmetics & Other Toilet Preparations Peers: Alterola Biotech Inc